Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | opioid receptor, mu 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | scavenger receptor class B type-2 (sr-B2) | 0.0131 | 0.0099 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 0.0071 | 0.7136 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.1469 | 0.2623 | 1 |
Echinococcus granulosus | CD36 class B scavenger receptor | 0.0131 | 0.0099 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0116 | 0.0071 | 0.0096 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0116 | 0.0071 | 0.0096 |
Echinococcus granulosus | CD36 class B scavenger receptor | 0.0131 | 0.0099 | 0.5 |
Mycobacterium leprae | PROBABLE DNA POLYMERASE I POLA | 0.0226 | 0.0279 | 0.5 |
Echinococcus granulosus | CD36 class B scavenger receptor | 0.0131 | 0.0099 | 0.5 |
Plasmodium vivax | telomerase reverse transcriptase, putative | 0.1469 | 0.2623 | 1 |
Echinococcus multilocularis | CD36 class B scavenger receptor | 0.0131 | 0.0099 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.0099 | 1 |
Schistosoma mansoni | CD36-like class B scavenger receptor | 0.0131 | 0.0099 | 1 |
Chlamydia trachomatis | DNA polymerase I | 0.0226 | 0.0279 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.0099 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.0099 | 1 |
Echinococcus multilocularis | lysosome membrane protein 2 | 0.0131 | 0.0099 | 0.5 |
Brugia malayi | CD36 family protein | 0.0131 | 0.0099 | 0.0135 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0116 | 0.0071 | 0.7136 |
Mycobacterium tuberculosis | Probable DNA polymerase I PolA | 0.0226 | 0.0279 | 1 |
Echinococcus multilocularis | CD36 class B scavenger receptor | 0.0131 | 0.0099 | 0.5 |
Mycobacterium ulcerans | DNA polymerase I | 0.0226 | 0.0279 | 1 |
Plasmodium falciparum | telomerase reverse transcriptase | 0.1469 | 0.2623 | 1 |
Giardia lamblia | Telomerase catalytic subunit | 0.1469 | 0.2623 | 0.5 |
Trypanosoma brucei | telomerase reverse transcriptase | 0.1469 | 0.2623 | 1 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.1469 | 0.2623 | 1 |
Echinococcus granulosus | lysosome membrane protein 2 | 0.0131 | 0.0099 | 0.5 |
Treponema pallidum | DNA polymerase I (polA) | 0.0226 | 0.0279 | 0.5 |
Brugia malayi | Telomerase reverse transcriptase | 0.3908 | 0.7228 | 1 |
Leishmania major | telomerase reverse transcriptase, putative | 0.1469 | 0.2623 | 1 |
Echinococcus multilocularis | CD36 class B scavenger receptor | 0.0131 | 0.0099 | 0.5 |
Echinococcus multilocularis | CD36 class B scavenger receptor | 0.0131 | 0.0099 | 0.5 |
Toxoplasma gondii | RNA-directed DNA polymerase | 0.1469 | 0.2623 | 1 |
Echinococcus granulosus | CD36 class B scavenger receptor | 0.0131 | 0.0099 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | DNA polymerase I | 0.0226 | 0.0279 | 0.5 |
Echinococcus multilocularis | CD36 class B scavenger receptor | 0.0131 | 0.0099 | 0.5 |
Echinococcus granulosus | CD36 class B scavenger receptor | 0.0131 | 0.0099 | 0.5 |
Schistosoma mansoni | CD36-like class B scavenger receptor | 0.0131 | 0.0099 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 6.7 | Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as beta-arrestin recruitment by chemiluminescence assay | ChEMBL. | 24063433 |
EC50 (functional) | = 7.3 | Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay | ChEMBL. | 24063433 |
Efficacy (binding) | = 13 % | Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as beta-arrestin recruitment by chemiluminescence assay relative to morphine | ChEMBL. | 24063433 |
Efficacy (functional) | = 84 % | Agonist activity at human mu opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation by fluorescence assay relative to morphine | ChEMBL. | 24063433 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.